Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 30/3/2020
SIETES contiene 92954 citas

 1 a 20 de 58 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Parthipan A, Banerjee I, Humphreys K, Asch SM, Curtin C, Carroll I, Hernandez-Boussard T. Predicting inadequate postoperative pain management in depressed patients: a machine learning approach. PLoS One 2019;14:6 de febrero. [Ref.ID 103058]
2.Enlace a cita original Cita con resumen
Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011–2016. National Vital Statistics Reports 2018;67:12 de diciembre. [Ref.ID 102871]
3.Enlace a cita original Cita con resumen
Howard R, Fry B, Gunaseelan V, Lee J, Waljee J, Brummett C, Campbell Jr D, Seese E, Englesbe M, Vu J. Association of opioid prescribing with opioid consumption after surgery in Michigan. JAMA Surgery 2018:7 de noviembre. [Ref.ID 102846]
4.Enlace a cita original Cita con resumen
Qato DM, Ozenberger K, Olfson M. Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA 2018;319:12 de junio. [Ref.ID 102780]
5.Enlace a cita original Cita con resumen
Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, Kroenke K, Bair MJ, Noorbaloochi S. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee ostoarthritis pain. The SPACE randomized clinical trial. JAMA 2018;319:6 de marzo. [Ref.ID 102554]
8.Tiene citas relacionadas Cita con resumen
Kyriacou DN. Opioid vs nonopioid acute pain management in the emergency department. JAMA 2017;318:1655-6. [Ref.ID 102136]
9. Cita con resumen
Becker WC, Fiellin DA. Abuse-deterrent opioid formulations - Putting the potential benefits into perspective. N Engl J Med 2017;376:2103-5. [Ref.ID 101625]
10. Cita con resumen
Shaheed CA, Maher CG, Williams KA, Day R, McLachlan AJ. Efficacy, tolerability, and dose-dependent effects of opioid analgesics for low back pain: a systematic review and meta-analysis. JAMA Intern Med 2016;176:958-68. [Ref.ID 100298]
11.Enlace a cita originalTiene citas relacionadas Cita con resumen
Dowell D, Haegerich TM. CDC guideline for prescribing opioids for chronic pain — United States, 2016. JAMA 2016;315:15 de marzo. [Ref.ID 100030]
12. Cita con resumen
Rudd RA, Aleshire N, Zibbell JE, Gladden M. Increases in drug and opioid overdose deaths — United States, 2000–2014. MMWR Morb Mortal Wkly Rep 2015;64:1-5. [Ref.ID 99739]
13. Cita con resumen
Qureshi WT, O'Neal WT, Khodneva Y, Judd S, Safford MM, Muntner P, Soliman EZ. Association between opioid use and atrial fibrillation. The Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. JAMA Intern Med 2015;175:junio. [Ref.ID 99002]
14. Cita con resumen
Anónimo. Advertisement FDA approves abuse-deterrent painkiller. DIA Daily 2014:21 de noviembre. [Ref.ID 98321]
15. Cita con resumen
Herman AO. Hydrocodone products to get more severe, schedule II classification. Journal Watch 2014:22 de agosto. [Ref.ID 97860]
16. Cita con resumen
Anónimo. Maker of opioid painkiller sues Massachusetts over ban on sale.. DIA Daily 2014:8 de abril. [Ref.ID 97392]
17.Enlace a cita original Cita con resumen
Young K. Groups ask FDA to keep Zohydro ER hydrocodone off the market. Physician's First Watch 2014:27 de febrero. [Ref.ID 97195]
18. Cita con resumen
Anónimo. Hydrocodone/chlorpheniramine (Vituz). Med Lett Drugs Ther 2013;55:95-6. [Ref.ID 96687]
19. Cita con resumen
Young K. 28 State AGs ask FDA to reconsider approval of Zohydro ER because of abuse potential. Journal Watch 2013:16 de diciembre. [Ref.ID 96622]
20. Cita con resumen
Anónimo. FDA approves first hydrocodone-only painkiller. DIA Daily 2013:28 de octubre. [Ref.ID 96252]
Seleccionar todas
 1 a 20 de 58 siguiente >>